Medication info
Rabeprazole Sodium 10 mg (Rabeprazole Sodium) Tablet

Rabeprazole Sodium 10 mg (Rabeprazole Sodium) Tablet

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›10mg / 1 tablet
Manufacturer / importer
Donggu Bio Pharmaceutical Co., Ltd.
Appearance
Yellowish round enteric-coated tablet
Packaging
28 tablets/box [14 tablets/Alu-Alu x 2]
Approval status
Active

MFDS item code 201310148 · Approved 2013.11.15 · Insurance code 657306150

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcers (including use with eradication therapy), and Zollinger-Ellison syndrome
Who takes it
Adults
Adult dose
Gastric and duodenal ulcers: The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), an additional 8 weeks of oral treatment with 10 mg or 20 mg twice daily may be given. However, 20 mg twice daily is for patients with confirmed severe mucosal damage only. Symptomatic relief of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, an on-demand regimen of 10 mg once daily may be used as needed to control subsequent symptoms. Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients infected with Helicobacter pylori should be treated with an eradication regimen. Concomitant administration of this medicine 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome: The recommended initial adult dose is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to individual patient needs. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have received this medicine for up to 1 year. ○ Patients with hepatic impairment Hepatic encephalopathy has been reported as an adverse reaction in patients with cirrhosis. Therefore, administer with caution. ○ Elderly patients Administer with caution, as hepatic function is often reduced.

Ingredients

Manufacturer
Donggu Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcers (including use with eradication therapy), and Zollinger-Ellison syndrome

  • Gastric ulcer
  • duodenal ulcer
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • gastrointestinal ulcers
  • Zollinger-Ellison syndrome
View approved original text

This medication helps treat ulcers of the stomach and duodenum, and alleviates symptoms associated with gastroesophageal reflux disease. It is also used as a long-term maintenance therapy for gastroesophageal reflux disease, and is administered in combination with antibiotics for patients with gastrointestinal ulcers infected by Helicobacter pylori. It is effective for the treatment of Zollinger-Ellison syndrome. Overall, it is used to improve various conditions related to gastrointestinal diseases.

How to take

Adult dose

Gastric and duodenal ulcers: The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), an additional 8 weeks of oral treatment with 10 mg or 20 mg twice daily may be given. However, 20 mg twice daily is for patients with confirmed severe mucosal damage only. Symptomatic relief of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, an on-demand regimen of 10 mg once daily may be used as needed to control subsequent symptoms. Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients infected with Helicobacter pylori should be treated with an eradication regimen. Concomitant administration of this medicine 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome: The recommended initial adult dose is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to individual patient needs. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have received this medicine for up to 1 year. ○ Patients with hepatic impairment Hepatic encephalopathy has been reported as an adverse reaction in patients with cirrhosis. Therefore, administer with caution. ○ Elderly patients Administer with caution, as hepatic function is often reduced.

Precautions

This medication should not be used by patients who are allergic or hypersensitive to certain components. Particular caution should be exercised in individuals who are allergic to penicillins or macrolide antibiotics. Pregnant or breastfeeding women should not take this medication. Patients with impaired liver function or the elderly should use this medication carefully, and caution is also necessary for those with a history of hypersensitivity to drugs. This medication can cause allergic symptoms such as skin rashes and itching, so it should be discontinued immediately if such symptoms occur. Regular blood tests or liver function tests are necessary, and if abnormal symptoms are found, immediate consultation with medical personnel is required. Care should also be taken in individuals with heart or vascular problems, or abnormal symptoms in the gastrointestinal tract. This medication may cause drowsiness, so caution should be exercised when driving or operating machinery. Long-term use may increase the risk of fractures, thus requiring regular check-ups and management. It may interact with other medications, so inform medical personnel of any medications being taken. Do not chew or crush the tablets; swallow them in their whole form, and keep out of reach of children. If symptoms such as diarrhea or difficulty breathing occur during use, inform medical personnel immediately, particularly since there is a risk of Clostridium difficile infection. From clinical trials and experiences, it should be remembered that regular check-ups and guidance from medical personnel are necessary for the safe use of this medication.

Side effects

Rash, urticaria, itching, erythrocyte decrease, leukocyte decrease, leukocytosis, eosinophilia, neutrophilia, lymphopenia, anemia, petechiae, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, elevated ALT, elevated AST, elevated ALP, elevated γ-GTP, elevated LDH, elevated total bilirubin, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, ECG abnormalities, migraine, syncope, angina, heart block, palpitations, tachycardia, bradycardia, pulmonary embolism, ventricular tachycardia, thrombophlebitis, vasodilation, prolonged QT interval, ventricular tachycardia, diarrhea, constipation, abdominal pain, abdominal bloating, dyspepsia, belching, nausea, rectal bleeding, hematochezia, anorexia, cholelithiasis, oral ulcers, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stools, colitis, esophagitis, glossitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, gastric body, gastritis, stomatitis, taste disturbances, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, fatty liver, salivary gland enlargement, thirst, headache, insomnia, anxiety, dizziness, seizures, abnormal dreams, decreased libido, neuropathy, sensory disturbances, tremors, weakness, neural hypersensitivity, drowsiness, vertigo, depression, agitation, amnesia, confusion, extrapyramidal syndrome, excessive blood circulation, upper and lower limb weakness, sensory impairment, decreased grip strength, language confusion, staggering, delirium, spatial disorientation, hypersomnia, cough, pharyngitis, rhinitis, dyspnea, asthma, epistaxis, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, aspiration pneumonia, myalgia, back pain, arthritis, leg cramps, bone pain, arthrosis, bursitis, generalized muscle hypertonicity, neuralgia, single contraction, sweating, alopecia, skin dryness, herpes zoster, psoriasis, skin color changes, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataract, amblyopia, glaucoma, dry eye, abnormal vision, tinnitus, otitis media, corneal opacity, blurriness, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, frequency of urination, dysmenorrhea, dysuria, kidney stones, uterine bleeding, polyuria, breast enlargement, hematuria, erectile dysfunction, vaginal discharge, menorrhagia, orchitis, urinary incontinence, interstitial nephritis, edema, elevated total cholesterol, elevated triglycerides, elevated BUN, elevated serum thyroid-stimulating hormone, chest pain, chills, fever, urinary tract infection, erythema, lethargy, weight gain, visual disturbances, loss of appetite, neck stiffness, photosensitivity reactions, hangover effects, weight loss, gout, anaphylaxis, shock, hepatitis, jaundice, hepatic encephalopathy, sudden death, coma, hyperammonemia, rhabdomyolysis, delirium, angioedema, hypomagnesemia, thrombocytopenia, neutropenia, vesicular skin rash, systemic allergic reactions, arthralgia, interstitial nephritis, gynecomastia, elevated thyroid-stimulating hormone, systemic lupus erythematosus, lupus erythematosus, lupus erythematosus, systemic lupus erythematosus, erythema, arthralgia, cytopenia, increased serum chromogranin A concentration, acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering. It is best kept at room temperature between 1°C and 30°C, away from extreme heat or cold.

Appearance and packaging

Appearance

Yellowish round enteric-coated tablet

Package unit

28 tablets/box [14 tablets/Alu-Alu x 2]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.